ask="2.75"
ask_size="100"
average_daily_volume="268328"
bid="1.25"
bid_size="400"
book_value="0.88"
change="-0.05"
change_from_200_day_moving_average="-1.46"
change_from_50_day_moving_average="-0.30"
change_from_52_week_high="-5.00"
change_From_52_week_low="0.00"
change_in_percent="-2.78%"
close="1.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="28175000"
high="1.85"
high_52_weeks="6.75"
last_trade_date="3/8/2017"
last_trade_price="1.75"
last_trade_size="4092"
last_trade_time="4:00pm"
low="1.75"
low_52_weeks="1.75"
market_capitalization="53.58M"
moving_average_200_day="3.21"
moving_average_50_day="2.05"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-45.50%"
percent_change_from_50_day_moving_average="-14.79%"
percent_change_from_52_week_high="-74.07%"
percent_change_from_52_week_low="+0.00%"
previous_close="1.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.06"
price_per_sales="140.52"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="12.29"
stock_exchange="NCM"
symbol="TROV"
volume="289314"
weeks_range_52="1.75 - 6.75"
